Table: Kringle Pharma - Q1 parent results

Kringle Pharma

12/02/2021 06:15

Feb 12 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Dec 31, 2020        Dec 31, 2019       Sep 30, 2021  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            94 mln                                206 mln     
                                                       (-55.9 pct)   
  Operating      loss 45 mln                            loss 1.04    
  Recurring      loss 61 mln                            loss 1.02    
  Net            loss 62 mln                            loss 1.02    
  EPS          loss 16.94 yen                        loss 245.19 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                                  NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T